Skip to content
Home
Get Involved
Conference
Donate
Donate Now
Store
What Is GSD?
Type Ia
Type Ib
Type II
Type III
Type IV
Type V
Type VI
Type VII
Type IX
Type 0
Type XI
Type XV
Other GSDs
News and Articles
About the Association
AGSD Governance
AGSD Scientific Advisory Board
Get Connected
AGSD Conference
Member Login
Member Login
agsdadmin
Home
»
Archives for agsdadmin
Ultragenyx Announces U.S. FDA Approval of GENGLYCOS™ Gene Therapy, the First-Ever FDA-Approved Treatment Designed to Treat the Underlying Cause of Glycogen Storage Disease Type Ia (GSDIa)
read more
Spring 2026 Newsletter
read more
Winter 2026 Ultragenyx Update
read more
Ultragenyx Update: DTX401 BLA Accepted
read more
Ultragenyx GSD1A Community Update Fall 2025
read more
Fall 2025 Newsletter
read more
Beam 301 -STRIVING FOR A NEW POTENTIAL THERAPY FOR GSD1a
read more
We Need Your Voice!
read more
Ultragenyx Announces Positive Longer-term Data from Phase 3 Study
read more
Introduction to Beam’s Clinical Development Program for GSD1a
read more
1
2
Next
Page load link
Go to Top